The Right to Use Kratom from the Psychiatric and Islamic Perspectives.
Addiction psychiatry
Islamic perspective
Kratom
Medicinal use
Journal
Journal of religion and health
ISSN: 1573-6571
Titre abrégé: J Relig Health
Pays: United States
ID NLM: 2985199R
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
10
5
2019
medline:
28
4
2021
entrez:
10
5
2019
Statut:
ppublish
Résumé
This paper aimed to summarize kratom's psychological effects on users and the Islamic views on kratom use. A literature survey of published kratom studies, teachings based on the holy Qur'an, the Sunnah, and views of several Islamic scholars based on qualitative methodology through text analysis was conducted. The results demonstrated that despite its beneficial therapeutic effects, the harm induced by kratom outweighs its benefits. We concluded that kratom use for medicinal purposes is only warranted if useful constituent mitragynine can be extracted and used on its own, and if more rigorous human studies demonstrated good safety profile and efficacy of mitragynine for therapeutic purposes.
Identifiants
pubmed: 31069602
doi: 10.1007/s10943-019-00830-w
pii: 10.1007/s10943-019-00830-w
doi:
Substances chimiques
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
841-853Références
Adkins, J. E., Boyer, E. W., & McCurdy, C. R. (2011). Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry, 11, 1165–1175.
pubmed: 21050173
Ahmad, K., & Aziz, Z. (2012). Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. Journal of Ethnopharmacology, 141, 446–450.
pubmed: 22440259
Al-Baqarah. (2010). Al-Quran. Selangor: Karangkraf.
al-Bazz. (2007). Tafsir al-Tarbawi li al–Quran al-Karim. Mesir: Darul An-Nashr li al-Jamia’ti.
Beckett, A. H., Shellard, E. J., & Tackie, A. N. (1965). The Mitragyna species of Asia- the alkaloids of the leaves of Mitragyna speciosa Korth: Isolation of mitragynine and speciofoline. Planta Medica, 13(2), 241–246.
Boyer, E. W., Babu, K. M., Adkins, J. E., McCurdy, C. R., & Halpern, J. H. (2008). Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa Korth). Addiction, 103, 1048–1050.
pubmed: 18482427
pmcid: 3670991
Chittrakarn, S., Sawangjaroen, K., Prasettho, S., Janchawee, B., & Keawpradub, N. (2008). Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth.) on the rat gastrointestinal tract. Journal of Ethnopharmacology, 116, 173–178.
pubmed: 18191353
Fluyau, D., & Revadigar, N. (2017). Biochemical benefits, diagnosis, and clinical risks evaluation of kratom. Frontiers in Psychiatry, 8, 62.
pubmed: 28484399
pmcid: 5402527
Ghazali. (2000). Al-Mustahfa Min Ilm al-Usul. Mesir: maktabah al-wahbah.
Grundmann, O. (2017). Patterns of Kratom use and health impact in the US: Results from an online survey. Drug and Alcohol Dependence, 176, 63–70.
pubmed: 28521200
Hambal, A. (1995). Musnad. Kaherah: Dar al-Hadis.
Harun, N., Hassan, Z., Navaratnam, V., Mansor, S. M., & Shoaib, M. (2015). Discriminative stimulus properties of mitragynine (kratom) in rats. Psychopharmacology (Berl), 232, 2227–2238.
Hassan, Z., Muzaimi, M., Navaratnam, V., Yusoff, H. M., Suhaimi, F. W., Vadivelu, R., et al. (2013). From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews, 37(2), 138–151.
pubmed: 23206666
Hemby, S. E., McIntosh, S., Leon, F., Cutler, S. J., & McCurdy, C. R. (2018). Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine. Addiction Biology. https://doi.org/10.1111/adb.12639 .
doi: 10.1111/adb.12639
pubmed: 29949228
Henningfield, J. E., Fant, R. V., & Wang, D. W. (2018). The abuse potential of kratom according the 8 factors of the controlled substances act: Implications for regulation and research. Psychopharmacology (Berl), 235, 573–589.
Ibn Majah. (2000). Sunnan ibn majah in mausu’ah alHadith al syarif alkutub alsittah. Riyadh: maktabah al, ma’arif al nasr wa al tawzi.
Idayu, N. F., Hidayat, M. T., Moklas, M. A., Sharida, F., Raudzah, A. R., Shamima, A. R., et al. (2011). Antidepressant-like effect of mitragynine isolated from Mitragyna speciose Korth in mice model of depression. Phytomedicine, 18(5), 402–407.
pubmed: 20869223
Ingsathit, A., Woratanarat, P., Anukarahanonta, T., Rattanasiri, S., Chatchaipun, P., Wattayakorn, K., et al. (2009). Prevalence of psychoactive drug use among drivers in Thailand: A roadside survey. Accident Analysis and Prevention, 41(3), 474–478.
pubmed: 19393795
Kapp, F. G., Maurer, H. H., Auwärter, V., Winkelmann, M., & Hermanns-Clausen, M. (2011). Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). Journal of Medical Toxicology, 7(3), 227–231.
pubmed: 21528385
pmcid: 3550198
Khor, B. S., Jamil, M. F., Adenan, M. I., & Shu-Chien, A. C. (2011). Mitragynine attenuates withdrawal syndrome in morphine-withdrawn Zebrafish. PLoS ONE, 6(12), e28340.
pubmed: 22205946
pmcid: 3244390
Kronstrand, R., Roman, M., Thelander, G., & Eriksson, A. (2011). Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton. Journal of Analytical Toxicology, 35(4), 242–247.
pubmed: 21513619
Kruegel, A. C., Gassaway, M. M., Kapoor, A., Váradi, A., Majumdar, S., Filizola, M., et al. (2016). Synthetic and receptor signalling explorations of the mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. Journal of the American Chemical Society, 138(21), 6754–6764.
pubmed: 27192616
pmcid: 5189718
Kumarnsit, E., Vongvatcharanon, U., Keawpradub, N., & Intasaro, P. (2007). Fos-like immunoreactivity in rat dorsal raphe nuclei induced by alkaloid extract of Mitragyna speciosa. Neuroscience Letter, 416, 128–132.
Lockyer, S. (2012). Textual Analysis. In Lisa M. Given (Ed.), The SAGE encyclopedia of qualitative research methods (pp. 865–866). Thousand Oaks: SAGE Publications Inc.
Macmillan, H. F. (1991). Tropical planting and gardening (6th ed.). Kuala Lumpur: Malayan Nature Society.
Matsumoto, K., Hatori, Y., Murayama, T., Tashima, K., Wongseripipatana, S., Misawa, K., et al. (2006). Involvement of μ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. European Journal of Pharmacology, 549(1–3), 63–70.
pubmed: 16978601
Matsumoto, K., Horie, S., Takayama, H., Ishikawa, H., Aimi, N., Ponglux, D., et al. (2005). Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, a alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Science, 78, 2–7.
Matsumoto, K., Takayama, H., Narita, M., Nakamura, A., Suzuki, M., Suzuki, T., et al. (2008). MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: A novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice. Neuropharmacology, 55(2), 154–165.
pubmed: 18550129
McWhirter, L., & Morris, S. (2010). A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. European Addiction Research, 16(4), 229–231.
pubmed: 20798544
Muslim, Abu al-Husain Bin Hujjaj Bin al-Qusyayri. (2003). Sahih Muslim. Kitab al-asyribah, books no. 36, no. hadith, 92. Kaherah: Dar al-Hadith.
Prozialeck, W. C., Jivan, J. K., & Ardurkar, V. (2012). Pharmachology of kratom: An emerging botanical agent with stimulant, analgesic nd opiod like effects. The Journal of the American Osteopathic Association, 112, 792–799.
pubmed: 23212430
Saingam, D., Assanangkornchai, S., Geater, A. F., & Balthip, Q. (2012). Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study. International Journal of Drug Policy, 24(4), 351–358.
pubmed: 23083922
Saingam, D., Assanangkornchai, S., Geater, A. F., & Balthip, Q. (2013). Pattern and consequences of krathom (Mitragyna speciosa Korth) use among male villagers in southern Thailand: A qualitative study. International Journal of Drug Policy, 24(4), 351–358.
pubmed: 23083922
Saingam, D., Assanangkornchai, S., Geater, A. F., & Lerkiatbundit, S. (2014). Validation of Krathom (Mitragyna speciosa Korth.) Dependence Scale (KDS): A dependence screen for internationally emerging psychoactive substance. Substance Abuse, 35(3), 276–283.
pubmed: 24853660
Saingam, D., Assanangkornchai, S., Geater, A. F., & Lerkiatbundit, S. (2016). Factor analytical investigation of Krathom (Mitragyna speciosa Korth.) withdrawal syndrome in Thailand. Journal of Psychoactive Drugs, 48(2), 76–85.
pubmed: 27015537
Sheleg, S. V., & Collins, G. B. (2011). A coincidence of addiction to kratom and severe primary hypothyroidism. Journal of Addiction Medicine, 5(4), 300–301.
pubmed: 21817918
Singh, D., Müller, C. P., & Vicknasigam, B. K. (2014). Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence, 139, 132–137.
pubmed: 24698080
Singh, D., Muller, C. P., Vicknasingam, B. K., & Mansor, S. M. (2015). Social functioning of kratom (Mitragyna speciosa) users in Malaysia. Journal of Psychoactive Drugs, 47(2), 125–131.
pubmed: 25950592
Singh, D., Narayanan, S., & Vicknasingam, B. (2016). Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin, 126(2016), 41–46.
pubmed: 27178014
Suhaimi, F. W., Yusoff, N. H. M., Hassan, R., Mansor, S. M., Navaratnam, V., Muller, C. P., et al. (2016). Neurobiology of kratom and its main alkaloid mitragynine. Brain Research Bulletin, 126(1), 29–40.
pubmed: 27018165
Suwanlert, S. (1975). A study of kratom eaters in Thailand. Bulletin on Narcotics, 27(3), 21–27.
pubmed: 1041694
Swogger, M. T., Hart, E., Erowid, F., Erowid, E., Trabold, N., Yee, K., et al. (2015). Experiences of kratom users: A qualitative analysis. Journal of Psychoactive Drugs, 47(5), 360–367.
pubmed: 26595229
Swogger, M. T., & Walsh, Z. (2018). Kratom use and mental health: A systematic review. Drug and Alcohol Dependence, 183, 134–140.
pubmed: 29248691
Tabari. (2000). Tafsir al-Tabari, Ditahqiq oleh Ahmad Syakir. Kaherah: Maktabah Ibn Taymiyyah.
Takayama, H. (2004). Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant: Mitragyna speciosa. Chemical and Pharmaceutical Bulletin, 52, 916–928.
pubmed: 15304982
Tanguay, P. (2011). Kratom in Thailand, decriminalisation and community control. Series on legislative reform of drug policies Nr. 13. Transnational Institute, International Drug Policy Consortium (IDPC).
Tungtananuwat, W., & Lawanprasert, S. (2010). Fatal 4 × 100; home-made kratom juice cocktail. Journal of Health Research, 24(1), 43–47.
Váradi, A., Marrone, G. F., Palmer, T. C., Narayan, A., Szabó, M. R., Le Rouzic, V., et al. (2016). Mitragynine/Corynantheidine pseudoindoxyls as opioid analgesics with Mu agonism and Delta antagonism, which do not recruit β-Arrestin-2. Journal of Medicinal Chemistry, 59(18), 8381–8397.
pubmed: 27556704
pmcid: 5344672
Vicknasingam, B., Narayanan, S., Goh, T. B., & Mansor, S. M. (2010). The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy, 21(4), 283–288.
pubmed: 20092998
Ward, J., Rosenbaum, C., Hernon, C., McCurdy, C. R., & Boyer, E. W. (2011). Herbal medicines for the management of opioid addiction: Safe and effective alternatives to conventional pharmacotherapy? CNS Drugs, 25, 999–1007.
pubmed: 22133323
Warner, M. L., Kaufman, N. C., & Grundmann, O. (2016). The pharmacology and toxicology of kratom: From traditional herb to drug of abuse. International Journal of Legal Medicine, 130(1), 127–138.
pubmed: 26511390
Yusuf al-Qaradawi. (1997). Al-Halal wa al-Haram fi al-Islam. Beirut: al-Maktab al-Islami.
Zuhailiy. (2000). Tafsir al-Munir fi al-cAqidah wa al-Sharicah wa al-Manhaj. Damsyiq: Dar al-Fikr al-Mucasir.
Zulkifli Al-Bakri. (2016). Irsyad Al-Fatwa Ke-124: Hukum Menanam Pokok Ketum Bagi Tujuan Perubatan & Farmaseutikal. http://Muftiwp.Gov.My/En/Artikel/Irsyad-Fatwa/Irsyad-Fatwa-Umum-Cat/1242-Irsyad-Al-Fatwa-Ke-124-Hukum-Menanam-Pokok-Ketum-Bagi-Tujuan-Perubatan-Farmaseutikal . Accessed 3 Sept 2018.